nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—Etoposide—muscle cancer	0.25	0.449	CbGbCtD
Montelukast—CYP2C8—Etoposide—muscle cancer	0.144	0.259	CbGbCtD
Montelukast—CYP3A4—Vincristine—muscle cancer	0.0638	0.115	CbGbCtD
Montelukast—CYP3A4—Etoposide—muscle cancer	0.0585	0.105	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—muscle cancer	0.0399	0.0717	CbGbCtD
Montelukast—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.00594	0.0142	CcSEcCtD
Montelukast—Erythema nodosum—Doxorubicin—muscle cancer	0.00584	0.0139	CcSEcCtD
Montelukast—Neuropathy—Vincristine—muscle cancer	0.00564	0.0135	CcSEcCtD
Montelukast—Neuropathy—Etoposide—muscle cancer	0.00457	0.0109	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0044	0.0105	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.0044	0.0105	CcSEcCtD
Montelukast—Liver disorder—Methotrexate—muscle cancer	0.00428	0.0102	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00393	0.00937	CcSEcCtD
Montelukast—Pneumonia—Dactinomycin—muscle cancer	0.00378	0.00903	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00373	0.0089	CcSEcCtD
Montelukast—Laryngitis—Doxorubicin—muscle cancer	0.0035	0.00836	CcSEcCtD
Montelukast—Dermatitis atopic—Doxorubicin—muscle cancer	0.00341	0.00814	CcSEcCtD
Montelukast—Pneumonia—Vincristine—muscle cancer	0.00338	0.00807	CcSEcCtD
Montelukast—Hepatitis—Dactinomycin—muscle cancer	0.00338	0.00806	CcSEcCtD
Montelukast—Pharyngitis—Dactinomycin—muscle cancer	0.00335	0.008	CcSEcCtD
Montelukast—Neuropathy peripheral—Vincristine—muscle cancer	0.00329	0.00786	CcSEcCtD
Montelukast—Otitis media—Doxorubicin—muscle cancer	0.00324	0.00774	CcSEcCtD
Montelukast—Bone disorder—Methotrexate—muscle cancer	0.00323	0.0077	CcSEcCtD
Montelukast—Erythema multiforme—Dactinomycin—muscle cancer	0.00319	0.00762	CcSEcCtD
Montelukast—Cramp muscle—Etoposide—muscle cancer	0.00318	0.00759	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00318	0.00759	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00312	0.00744	CcSEcCtD
Montelukast—Hallucination—Vincristine—muscle cancer	0.003	0.00717	CcSEcCtD
Montelukast—Hypoaesthesia—Vincristine—muscle cancer	0.003	0.00717	CcSEcCtD
Montelukast—Liver injury—Doxorubicin—muscle cancer	0.003	0.00716	CcSEcCtD
Montelukast—Vasculitis—Methotrexate—muscle cancer	0.00299	0.00713	CcSEcCtD
Montelukast—Urinary tract disorder—Vincristine—muscle cancer	0.00298	0.00711	CcSEcCtD
Montelukast—Connective tissue disorder—Vincristine—muscle cancer	0.00296	0.00708	CcSEcCtD
Montelukast—Urethral disorder—Vincristine—muscle cancer	0.00296	0.00706	CcSEcCtD
Montelukast—Cardiac disorder—Vincristine—muscle cancer	0.0028	0.00668	CcSEcCtD
Montelukast—Viral infection—Doxorubicin—muscle cancer	0.00279	0.00667	CcSEcCtD
Montelukast—Bone disorder—Doxorubicin—muscle cancer	0.00279	0.00667	CcSEcCtD
Montelukast—CYSLTR1—smooth muscle tissue—muscle cancer	0.00276	0.113	CbGeAlD
Montelukast—Pneumonia—Etoposide—muscle cancer	0.00274	0.00654	CcSEcCtD
Montelukast—Infestation—Etoposide—muscle cancer	0.00272	0.0065	CcSEcCtD
Montelukast—Infestation NOS—Etoposide—muscle cancer	0.00272	0.0065	CcSEcCtD
Montelukast—Mediastinal disorder—Vincristine—muscle cancer	0.00272	0.00649	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.0027	0.00644	CcSEcCtD
Montelukast—Neuropathy peripheral—Etoposide—muscle cancer	0.00267	0.00637	CcSEcCtD
Montelukast—Jaundice—Etoposide—muscle cancer	0.00265	0.00633	CcSEcCtD
Montelukast—Mental disorder—Vincristine—muscle cancer	0.00264	0.00631	CcSEcCtD
Montelukast—Hepatobiliary disease—Etoposide—muscle cancer	0.00257	0.00615	CcSEcCtD
Montelukast—Hepatocellular injury—Doxorubicin—muscle cancer	0.00252	0.00603	CcSEcCtD
Montelukast—Myalgia—Dactinomycin—muscle cancer	0.0025	0.00597	CcSEcCtD
Montelukast—Hypoaesthesia—Etoposide—muscle cancer	0.00243	0.0058	CcSEcCtD
Montelukast—Urinary tract disorder—Etoposide—muscle cancer	0.00241	0.00576	CcSEcCtD
Montelukast—Agitation—Vincristine—muscle cancer	0.00241	0.00576	CcSEcCtD
Montelukast—Oedema—Dactinomycin—muscle cancer	0.0024	0.00573	CcSEcCtD
Montelukast—Urethral disorder—Etoposide—muscle cancer	0.0024	0.00572	CcSEcCtD
Montelukast—Infection—Dactinomycin—muscle cancer	0.00238	0.00569	CcSEcCtD
Montelukast—Neuropathy—Doxorubicin—muscle cancer	0.00237	0.00566	CcSEcCtD
Montelukast—Thrombocytopenia—Dactinomycin—muscle cancer	0.00235	0.00561	CcSEcCtD
Montelukast—Erythema multiforme—Etoposide—muscle cancer	0.00231	0.00552	CcSEcCtD
Montelukast—Convulsion—Vincristine—muscle cancer	0.00228	0.00543	CcSEcCtD
Montelukast—Cardiac disorder—Etoposide—muscle cancer	0.00227	0.00541	CcSEcCtD
Montelukast—Myalgia—Vincristine—muscle cancer	0.00224	0.00534	CcSEcCtD
Montelukast—Immune system disorder—Etoposide—muscle cancer	0.00221	0.00527	CcSEcCtD
Montelukast—Mediastinal disorder—Etoposide—muscle cancer	0.0022	0.00526	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00219	0.00522	CcSEcCtD
Montelukast—Anaphylactic shock—Vincristine—muscle cancer	0.00214	0.00512	CcSEcCtD
Montelukast—Oedema—Vincristine—muscle cancer	0.00214	0.00512	CcSEcCtD
Montelukast—Infection—Vincristine—muscle cancer	0.00213	0.00508	CcSEcCtD
Montelukast—Nervous system disorder—Vincristine—muscle cancer	0.0021	0.00502	CcSEcCtD
Montelukast—Thrombocytopenia—Vincristine—muscle cancer	0.0021	0.00501	CcSEcCtD
Montelukast—Fatigue—Dactinomycin—muscle cancer	0.00207	0.00494	CcSEcCtD
Montelukast—Pain—Dactinomycin—muscle cancer	0.00205	0.0049	CcSEcCtD
Montelukast—Muscle spasms—Etoposide—muscle cancer	0.00205	0.00488	CcSEcCtD
Montelukast—Eczema—Doxorubicin—muscle cancer	0.00204	0.00487	CcSEcCtD
Montelukast—Irritability—Methotrexate—muscle cancer	0.00202	0.00482	CcSEcCtD
Montelukast—CYSLTR1—bone marrow—muscle cancer	0.00201	0.0821	CbGeAlD
Montelukast—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00196	0.00468	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00195	0.00466	CcSEcCtD
Montelukast—Insomnia—Vincristine—muscle cancer	0.00194	0.00463	CcSEcCtD
Montelukast—CYSLTR1—vagina—muscle cancer	0.00193	0.0786	CbGeAlD
Montelukast—Paraesthesia—Vincristine—muscle cancer	0.00192	0.00459	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00191	0.00455	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—muscle cancer	0.0019	0.00453	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—muscle cancer	0.0019	0.00453	CcSEcCtD
Montelukast—Cough—Etoposide—muscle cancer	0.00186	0.00443	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vincristine—muscle cancer	0.00185	0.00442	CcSEcCtD
Montelukast—Fatigue—Vincristine—muscle cancer	0.00185	0.00441	CcSEcCtD
Montelukast—Convulsion—Etoposide—muscle cancer	0.00184	0.0044	CcSEcCtD
Montelukast—Pain—Vincristine—muscle cancer	0.00183	0.00438	CcSEcCtD
Montelukast—Asthma—Methotrexate—muscle cancer	0.00183	0.00437	CcSEcCtD
Montelukast—Eosinophilia—Methotrexate—muscle cancer	0.00181	0.00432	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0018	0.00429	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—muscle cancer	0.00179	0.00428	CcSEcCtD
Montelukast—CYSLTR1—head—muscle cancer	0.00178	0.0726	CbGeAlD
Montelukast—Hypersensitivity—Dactinomycin—muscle cancer	0.00177	0.00422	CcSEcCtD
Montelukast—Gastrointestinal pain—Vincristine—muscle cancer	0.00175	0.00418	CcSEcCtD
Montelukast—Anaphylactic shock—Etoposide—muscle cancer	0.00174	0.00414	CcSEcCtD
Montelukast—Infection—Etoposide—muscle cancer	0.00173	0.00412	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—muscle cancer	0.00172	0.00411	CcSEcCtD
Montelukast—Thrombocytopenia—Etoposide—muscle cancer	0.0017	0.00406	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0017	0.00406	CcSEcCtD
Montelukast—Body temperature increased—Vincristine—muscle cancer	0.00169	0.00404	CcSEcCtD
Montelukast—Abdominal pain—Vincristine—muscle cancer	0.00169	0.00404	CcSEcCtD
Montelukast—Skin disorder—Etoposide—muscle cancer	0.00169	0.00403	CcSEcCtD
Montelukast—ALOX5—smooth muscle tissue—muscle cancer	0.00167	0.0683	CbGeAlD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00165	0.00394	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00165	0.00394	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—muscle cancer	0.00164	0.00392	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—muscle cancer	0.00164	0.00392	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—muscle cancer	0.00164	0.00391	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—muscle cancer	0.00163	0.00389	CcSEcCtD
Montelukast—Infestation—Methotrexate—muscle cancer	0.00163	0.00389	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—muscle cancer	0.00163	0.00389	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00162	0.00386	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00162	0.00386	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—muscle cancer	0.00159	0.00378	CcSEcCtD
Montelukast—Asthma—Doxorubicin—muscle cancer	0.00158	0.00378	CcSEcCtD
Montelukast—Influenza—Doxorubicin—muscle cancer	0.00158	0.00378	CcSEcCtD
Montelukast—Hypersensitivity—Vincristine—muscle cancer	0.00158	0.00377	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—muscle cancer	0.00157	0.00374	CcSEcCtD
Montelukast—Paraesthesia—Etoposide—muscle cancer	0.00156	0.00372	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—muscle cancer	0.00155	0.00371	CcSEcCtD
Montelukast—Somnolence—Etoposide—muscle cancer	0.00154	0.00368	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—muscle cancer	0.00154	0.00368	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—muscle cancer	0.00154	0.00367	CcSEcCtD
Montelukast—Asthenia—Vincristine—muscle cancer	0.00154	0.00367	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—muscle cancer	0.00153	0.00364	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—muscle cancer	0.00152	0.00364	CcSEcCtD
Montelukast—Rash—Dactinomycin—muscle cancer	0.00151	0.00361	CcSEcCtD
Montelukast—Gastrointestinal disorder—Etoposide—muscle cancer	0.0015	0.00358	CcSEcCtD
Montelukast—Fatigue—Etoposide—muscle cancer	0.0015	0.00357	CcSEcCtD
Montelukast—Pain—Etoposide—muscle cancer	0.00148	0.00354	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00147	0.00351	CcSEcCtD
Montelukast—Diarrhoea—Vincristine—muscle cancer	0.00147	0.0035	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—muscle cancer	0.00146	0.00349	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—muscle cancer	0.00145	0.00347	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—muscle cancer	0.00145	0.00345	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—muscle cancer	0.00144	0.00343	CcSEcCtD
Montelukast—Nausea—Dactinomycin—muscle cancer	0.00143	0.0034	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—muscle cancer	0.00142	0.00339	CcSEcCtD
Montelukast—Gastrointestinal pain—Etoposide—muscle cancer	0.00142	0.00339	CcSEcCtD
Montelukast—Dizziness—Vincristine—muscle cancer	0.00142	0.00338	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—muscle cancer	0.00141	0.00337	CcSEcCtD
Montelukast—Infestation—Doxorubicin—muscle cancer	0.00141	0.00337	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—muscle cancer	0.00141	0.00337	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.0014	0.00334	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—muscle cancer	0.00138	0.0033	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00138	0.0033	CcSEcCtD
Montelukast—Urticaria—Etoposide—muscle cancer	0.00138	0.00329	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—muscle cancer	0.00138	0.00329	CcSEcCtD
Montelukast—Abdominal pain—Etoposide—muscle cancer	0.00137	0.00328	CcSEcCtD
Montelukast—Body temperature increased—Etoposide—muscle cancer	0.00137	0.00328	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—muscle cancer	0.00137	0.00328	CcSEcCtD
Montelukast—Vomiting—Vincristine—muscle cancer	0.00136	0.00325	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—muscle cancer	0.00136	0.00324	CcSEcCtD
Montelukast—Rash—Vincristine—muscle cancer	0.00135	0.00323	CcSEcCtD
Montelukast—Dermatitis—Vincristine—muscle cancer	0.00135	0.00322	CcSEcCtD
Montelukast—Headache—Vincristine—muscle cancer	0.00134	0.00321	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00134	0.00319	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—muscle cancer	0.00133	0.00318	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—muscle cancer	0.00132	0.00316	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—muscle cancer	0.00132	0.00316	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—muscle cancer	0.00132	0.00315	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—muscle cancer	0.00128	0.00306	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—muscle cancer	0.00128	0.00305	CcSEcCtD
Montelukast—Nausea—Vincristine—muscle cancer	0.00127	0.00304	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—muscle cancer	0.00127	0.00303	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—muscle cancer	0.00127	0.00303	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—muscle cancer	0.00126	0.00301	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—muscle cancer	0.00126	0.003	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—muscle cancer	0.00125	0.00299	CcSEcCtD
Montelukast—Asthenia—Etoposide—muscle cancer	0.00125	0.00297	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—muscle cancer	0.00125	0.00297	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—muscle cancer	0.00124	0.00297	CcSEcCtD
Montelukast—SLCO2B1—renal system—muscle cancer	0.00124	0.0506	CbGeAlD
Montelukast—Pruritus—Etoposide—muscle cancer	0.00123	0.00293	CcSEcCtD
Montelukast—ALOX5—bone marrow—muscle cancer	0.00122	0.0497	CbGeAlD
Montelukast—Erythema multiforme—Doxorubicin—muscle cancer	0.0012	0.00286	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—muscle cancer	0.00119	0.00284	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—muscle cancer	0.00118	0.00281	CcSEcCtD
Montelukast—Dizziness—Etoposide—muscle cancer	0.00115	0.00274	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—muscle cancer	0.00115	0.00273	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—muscle cancer	0.00114	0.00273	CcSEcCtD
Montelukast—Cough—Methotrexate—muscle cancer	0.00111	0.00265	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—muscle cancer	0.00111	0.00265	CcSEcCtD
Montelukast—Convulsion—Methotrexate—muscle cancer	0.0011	0.00264	CcSEcCtD
Montelukast—Vomiting—Etoposide—muscle cancer	0.0011	0.00264	CcSEcCtD
Montelukast—Rash—Etoposide—muscle cancer	0.00109	0.00261	CcSEcCtD
Montelukast—Dermatitis—Etoposide—muscle cancer	0.00109	0.00261	CcSEcCtD
Montelukast—Headache—Etoposide—muscle cancer	0.00109	0.0026	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—muscle cancer	0.00109	0.00259	CcSEcCtD
Montelukast—Myalgia—Methotrexate—muscle cancer	0.00109	0.00259	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00108	0.00257	CcSEcCtD
Montelukast—ALOX5—head—muscle cancer	0.00108	0.044	CbGeAlD
Montelukast—Muscle spasms—Doxorubicin—muscle cancer	0.00106	0.00253	CcSEcCtD
Montelukast—ALOX5—testis—muscle cancer	0.00104	0.0425	CbGeAlD
Montelukast—Anaphylactic shock—Methotrexate—muscle cancer	0.00104	0.00248	CcSEcCtD
Montelukast—Infection—Methotrexate—muscle cancer	0.00103	0.00247	CcSEcCtD
Montelukast—Nausea—Etoposide—muscle cancer	0.00103	0.00246	CcSEcCtD
Montelukast—CYP2A6—vagina—muscle cancer	0.00103	0.042	CbGeAlD
Montelukast—Nervous system disorder—Methotrexate—muscle cancer	0.00102	0.00243	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—muscle cancer	0.00102	0.00243	CcSEcCtD
Montelukast—Agitation—Doxorubicin—muscle cancer	0.00101	0.00242	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—muscle cancer	0.00101	0.00241	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—muscle cancer	0.000975	0.00233	CcSEcCtD
Montelukast—SLCO2B1—tendon—muscle cancer	0.000967	0.0395	CbGeAlD
Montelukast—Cough—Doxorubicin—muscle cancer	0.000963	0.0023	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—muscle cancer	0.000956	0.00228	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000948	0.00226	CcSEcCtD
Montelukast—Insomnia—Methotrexate—muscle cancer	0.000941	0.00225	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—muscle cancer	0.00094	0.00224	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—muscle cancer	0.00094	0.00224	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—muscle cancer	0.000936	0.00223	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—muscle cancer	0.000934	0.00223	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000933	0.00223	CcSEcCtD
Montelukast—Somnolence—Methotrexate—muscle cancer	0.000925	0.00221	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—muscle cancer	0.000916	0.00219	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—muscle cancer	0.000901	0.00215	CcSEcCtD
Montelukast—Oedema—Doxorubicin—muscle cancer	0.000901	0.00215	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000898	0.00214	CcSEcCtD
Montelukast—Fatigue—Methotrexate—muscle cancer	0.000897	0.00214	CcSEcCtD
Montelukast—Infection—Doxorubicin—muscle cancer	0.000895	0.00214	CcSEcCtD
Montelukast—Pain—Methotrexate—muscle cancer	0.000889	0.00212	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—muscle cancer	0.000883	0.00211	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—muscle cancer	0.000882	0.0021	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—muscle cancer	0.000875	0.00209	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—muscle cancer	0.000851	0.00203	CcSEcCtD
Montelukast—SLCO2B1—head—muscle cancer	0.000829	0.0339	CbGeAlD
Montelukast—Urticaria—Methotrexate—muscle cancer	0.000826	0.00197	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—muscle cancer	0.000822	0.00196	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—muscle cancer	0.000822	0.00196	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000821	0.00196	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—muscle cancer	0.000815	0.00194	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—muscle cancer	0.000809	0.00193	CcSEcCtD
Montelukast—SLCO2B1—testis—muscle cancer	0.000801	0.0327	CbGeAlD
Montelukast—Somnolence—Doxorubicin—muscle cancer	0.000801	0.00191	CcSEcCtD
Montelukast—CYP2C8—renal system—muscle cancer	0.000797	0.0325	CbGeAlD
Montelukast—Dyspepsia—Doxorubicin—muscle cancer	0.000793	0.00189	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000778	0.00186	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—muscle cancer	0.000776	0.00185	CcSEcCtD
Montelukast—Pain—Doxorubicin—muscle cancer	0.00077	0.00184	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—muscle cancer	0.000766	0.00183	CcSEcCtD
Montelukast—Asthenia—Methotrexate—muscle cancer	0.000746	0.00178	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000736	0.00176	CcSEcCtD
Montelukast—Pruritus—Methotrexate—muscle cancer	0.000736	0.00176	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—muscle cancer	0.000715	0.00171	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—muscle cancer	0.000712	0.0017	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—muscle cancer	0.000712	0.0017	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—muscle cancer	0.000712	0.0017	CcSEcCtD
Montelukast—Dizziness—Methotrexate—muscle cancer	0.000688	0.00164	CcSEcCtD
Montelukast—PTGS1—smooth muscle tissue—muscle cancer	0.000671	0.0274	CbGeAlD
Montelukast—Hypersensitivity—Doxorubicin—muscle cancer	0.000664	0.00158	CcSEcCtD
Montelukast—Vomiting—Methotrexate—muscle cancer	0.000661	0.00158	CcSEcCtD
Montelukast—Rash—Methotrexate—muscle cancer	0.000656	0.00157	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—muscle cancer	0.000655	0.00156	CcSEcCtD
Montelukast—Headache—Methotrexate—muscle cancer	0.000652	0.00156	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—muscle cancer	0.000646	0.00154	CcSEcCtD
Montelukast—PTGS1—renal system—muscle cancer	0.000646	0.0264	CbGeAlD
Montelukast—Pruritus—Doxorubicin—muscle cancer	0.000637	0.00152	CcSEcCtD
Montelukast—Nausea—Methotrexate—muscle cancer	0.000618	0.00147	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—muscle cancer	0.000616	0.00147	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—muscle cancer	0.000596	0.00142	CcSEcCtD
Montelukast—PTGS1—cardiac atrium—muscle cancer	0.000579	0.0236	CbGeAlD
Montelukast—CYP2C8—vagina—muscle cancer	0.000577	0.0236	CbGeAlD
Montelukast—Vomiting—Doxorubicin—muscle cancer	0.000573	0.00137	CcSEcCtD
Montelukast—Rash—Doxorubicin—muscle cancer	0.000568	0.00136	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—muscle cancer	0.000567	0.00135	CcSEcCtD
Montelukast—Headache—Doxorubicin—muscle cancer	0.000564	0.00135	CcSEcCtD
Montelukast—CYP3A4—renal system—muscle cancer	0.00054	0.022	CbGeAlD
Montelukast—Nausea—Doxorubicin—muscle cancer	0.000535	0.00128	CcSEcCtD
Montelukast—CYP2C8—testis—muscle cancer	0.000515	0.021	CbGeAlD
Montelukast—PTGS1—tendon—muscle cancer	0.000504	0.0206	CbGeAlD
Montelukast—PTGS1—vagina—muscle cancer	0.000468	0.0191	CbGeAlD
Montelukast—PTGS1—head—muscle cancer	0.000432	0.0177	CbGeAlD
Montelukast—PTGS1—testis—muscle cancer	0.000418	0.0171	CbGeAlD
